Chemours Company
(CC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2012 | 12-2006 | |
| Sales | 6,432,000 | 6,859,000 | 7,365,000 | 0 |
| Cost of Goods | 5,072,000 | 5,395,000 | 5,014,000 | N/A |
| Gross Profit | 1,360,000 | 1,464,000 | 2,351,000 | N/A |
| Operating Expenses | 849,000 | 934,000 | 928,000 | 0 |
| Operating Income | 511,000 | 530,000 | 1,423,000 | N/A |
| Other Income | 39,000 | 46,000 | 62,000 | 0 |
| Pre-tax Income | 550,000 | 576,000 | 1,485,000 | 0 |
| Income Tax | 149,000 | 152,000 | 427,000 | N/A |
| Net Income Continuous | 401,000 | 424,000 | 1,058,000 | N/A |
| Minority Interests | 1,000 | 1,000 | 1,000 | N/A |
| Net Income | $400,000 | $423,000 | $1,057,000 | $N/A |
| EPS Basic Total Ops | 2.21 | 2.34 | N/A | N/A |
| EPS Basic Continuous Ops | 2.22 | 2.34 | N/A | N/A |
| EPS Diluted Total Ops | 2.21 | 2.34 | N/A | N/A |
| EPS Diluted Continuous Ops | 2.22 | 2.34 | N/A | N/A |
| EBITDA(a) | $768,000 | $791,000 | $1,689,000 | $N/A |